Tracked deals
4
4 tracked deals across 2021-2024.
Bilthoven, Netherlands
Formerly known as Avania (Bilthoven, Netherlands), Factory-CRO Group, Factory-CRO Group (Avania)
Global MedTech contract research organization (CRO) built for medical technology innovators, integrating regulatory strategy, clinical development, and market access/reimbursement to take products from concept to commercialization.
Tracked deals
4
4 tracked deals across 2021-2024.
Recent pace
0
0 tracked deals announced in the last 12 months.
Deal mix
Buyout
3 buyout · 1 addon
Last 3 years
Supporting Data
Avania, a global MedTech contract research organization (CRO), has acquired Anagram, a Barcelona-based MedTech CRO, to expand its CRO footprint into Spain and Southern Europe. The acquisition adds Anagram’s imaging core lab and therapeutic expertise in cardiology, neurology and oncology, strengthening Avania’s regional presence and clinical capabilities.
Avania, a global MedTech contract research organization based in the Netherlands, has acquired HULL ASSOCIATES LLC (Boston) and Ironstone Product Development (IPD) (Toronto) to strengthen its engineering design, product development, regulatory, and market access capabilities across medical devices, diagnostics and related product categories. The acquisitions expand Avania's strategic expertise in market access/reimbursement, health economics, early product development, and regulatory strategy to better support MedTech innovators from development through commercialization.
Avania, the Bilthoven-based MedTech-focused contract research organization (CRO), has acquired MAXIS, a medical-technology development services provider with offices in San Jose, California and Frankfurt am Main, Germany. The deal expands Avania's pre-clinical engineering, design validation, regulatory affairs, and field clinical/trial management capabilities and extends its international footprint.
Avania, a global medical-technology contract research organization (CRO) based in Bilthoven, Netherlands, has acquired IMARC, a Strongsville, Ohio–based medical device CRO. The acquisition expands Avania's U.S. footprint and capabilities in device clinical research (monitoring, auditing, safety, data management and training) while providing IMARC clients access to Avania's international network and enhanced services.
Turn tracked acquisition activity into an outreach-ready buyer list.